PRISM

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD

Keywords IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy +2 more
Started
2016-04-01
f27f2c72-5f11-11eb-917b-acde48001122